Barcelona, Spain

Jordi Morral Cardoner

This inventor holds 1 USPTO granted patent. Top assignee: Medichem, S.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jordi Morral Cardoner. Retrieved from https://idiyas.com/inventor/jordi-morral-cardoner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jordi Morral Cardoner

Introduction

Jordi Morral Cardoner is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the creation of a patent that showcases his innovative approach to solving complex problems.

Latest Patents

Jordi holds a patent for polycyclic aminopyridine compounds which are acetylcholinesterase inhibitors. This invention is crucial in the development of treatments for various neurological conditions. His patent portfolio includes 1 patent that reflects his expertise and dedication to advancing scientific knowledge.

Career Highlights

Jordi is currently employed at Medichem, S.A., a company known for its commitment to pharmaceutical innovation. His role at Medichem allows him to collaborate with other talented professionals in the industry. His contributions have been instrumental in driving forward the company's research initiatives.

Collaborations

Throughout his career, Jordi has worked alongside esteemed colleagues such as Pelayo Camps Garcia and Diego Munoz-Torrero Lopez-Ibarra. These collaborations have enriched his work and fostered a creative environment for innovation.

Conclusion

Jordi Morral Cardoner exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…